Syntekabio has developed a breakthrough technology DeepMatcher®, a proprietary AI drug discovery cloud platform, that screens more than 1 billion commercially available compounds against over 1700 target proteins—both wild and mutated—identified by genomic big data analysis. DeepMatcher® derives efficiently new small molecule drug candidates and optimizes complex three-dimensional drug-target structures by adopting AI-based best pose, receptor-ligand binding energy and molecular dynamics simulation.